[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100548081":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":30,"centralContacts":34,"locations":39,"responsibleParty":82,"collaborators":85,"id":88,"slug":89,"hasResults":90,"nctId":91,"briefTitle":92,"officialTitle":92,"acronym":25,"eligibilityCriteria":93,"healthyVolunteers":90,"sex":94,"minAge":25,"maxAge":25,"enrollmentInfo":95,"targetDuration":25,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":63,"whyStopped":25,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Amsterdam UMC, location VUmc","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention Group","EXPERIMENTAL","At-home use of the Cue2Walk",[13],"Device: Cue2Walk",{"label":15,"type":6,"description":16,"interventionNames":17},"Control Group","Usual Care (+ Waiting List)",[18],"Other: Usual Care",[20,26],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DEVICE","Cue2Walk","24 weeks of using of the Cue2Walk device in the own living environment + 8 weeks of naturalistic follow-up",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"Usual Care","24 weeks of receiving usual care + 8 weeks of using of the Cue2Walk device in the own living environment",[15],[31],{"name":32,"affiliation":5,"role":33},"Erwin EH van Wegen, PhD","PRINCIPAL_INVESTIGATOR",[35],{"name":32,"role":36,"phone":37,"phoneExt":25,"email":38},"CONTACT","020-4440461","e.vanwegen@amsterdamumc.nl",[40,62],{"facility":41,"status":42,"city":43,"state":44,"zip":45,"country":46,"countryCode":47,"cosmosGeoPoint":48,"geoPoint":53,"contacts":54},"Radboudumc","NOT_YET_RECRUITING","Nijmegen","Gelderland","6525 GA","Netherlands","NL",{"type":49,"coordinates":50},"Point",[51,52],5.85278,51.8425,{"lat":52,"lon":51},[55,58,59],{"name":56,"role":36,"phone":25,"phoneExt":25,"email":57},"Jorik Nonnekes, MD, PhD","Jorik.Nonnekes@radboudumc.nl",{"name":56,"role":33,"phone":25,"phoneExt":25,"email":25},{"name":60,"role":61,"phone":25,"phoneExt":25,"email":25},"Lotte van de Venis, PhD","SUB_INVESTIGATOR",{"facility":5,"status":63,"city":64,"state":65,"zip":66,"country":46,"countryCode":47,"cosmosGeoPoint":67,"geoPoint":71,"contacts":72},"RECRUITING","Amsterdam","North Holland","1081HZ",{"type":49,"coordinates":68},[69,70],4.88969,52.37403,{"lat":70,"lon":69},[73,75,76,78,80],{"name":74,"role":36,"phone":37,"phoneExt":25,"email":38},"Erwin EH van Wegen, Dr.",{"name":32,"role":33,"phone":25,"phoneExt":25,"email":25},{"name":77,"role":61,"phone":25,"phoneExt":25,"email":25},"Matthijs van der Laan, MSc",{"name":79,"role":61,"phone":25,"phoneExt":25,"email":25},"Marc B. Rietberg, PhD",{"name":81,"role":61,"phone":25,"phoneExt":25,"email":25},"Vincent de Groot, Prof. dr.",{"type":33,"investigatorFullName":83,"investigatorTitle":84,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"Dr. Erwin E. H. van Wegen","Principal Investigator, Associate Professor Neurorehabilitation",[86],{"name":87,"class":6},"Radboud University Medical Center","100548081","cue2walk-cost-effectiveness-of-automated-freezing-detection-and-provision-of-external-cues-in-comparison-to-usual-care-in-people-with-parkinsons-disease-100548081",false,"NCT06416345","Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease","Inclusion Criteria:\n\n* Diagnosis of Parkinson's disease according to UK Brain bank criteria\n* Daily Freezing of Gait\n* Hoehn-Yahr stage 2-4\n* Stable medication regime and\u002For DBS settings as determined by the treating neurologist\n* Ability to walk 5 minutes while unassisted by another person\n\nExclusion Criteria:\n\n* Participation in another clinical study\n* Use of a personal cueing device at home\n* Previous use of the Cue2Walk medical device\n* Presence of co-morbidities that would hamper participation\n* Cognitive impairment preventing understanding of therapeutic instructions (Montreal Cognitive Assessment (MoCA) Score \\\u003C16)","ALL",{"count":96,"type":97},84,"ESTIMATED","INTERVENTIONAL",[100],"NA","The majority of people with Parkinson's disease incur Freezing of Gait (FoG), which is not addressed adequately by medication. Cueing is a proven strategy to overcome FoG. The Cue2Walk is a device with automated detection of FoG and provision of rhythmic cues. In this study, the (cost-)effectiveness of the Cue2Walk device as compared to usual care is investigated.",[103],"Parkinson Disease",[105,106,107,108],"Parkinson's Disease","Freezing of Gait","(Smart) Cueing","Costeffectiveness","2026-03-12",{"date":111,"type":112},"2026-03-16","ACTUAL",{"date":114,"type":112},"2025-08-22",{"date":116,"type":97},"2027-12-01",{"name":5,"class":6},2]